Rising chorus of concern over Sputnik V vaccine stems from opaque development and lack of mass-testing.
In 1977 Scott Halstead, a virologist at the University of Hawaii, was studying dengue fever when he noticed a now well-known but then unexpected feature of the disease.
Animals that had already been exposed to one of the four closely-related viruses that cause dengue and produced antibodies to it, far from being protected against other versions became sicker when infected a second time, and it was the antibodies already produced by the first infection that were responsible, allowing the second infection to hitchhike into the body.
The effect was called antibody-dependent enhancement (ADE). The reason it matters today, in the midst of the coronavirus pandemic, is because unexpected glitches like ADE are the kind of problems vaccine developers look for in phase 3 testing of vaccines – testing which has yet to be carried out on Russia’s newly-approved Sputnik V vaccine.
ADE “is a genuine concern”, virologist Kevin Gilligan, a senior consultant with Biologics Consulting, told Nature Biotechnology in June. “Because if the gun is jumped, and a vaccine is widely distributed that is disease enhancing, that would be worse than actually not doing any vaccination at all.”
This week, following Russia’s announcement that it is pushing ahead with mass production of Sputnik V and mass inoculation , the fears expressed by the likes of Gilligan became a chorus, underlining the genuine concerns among scientists that Russian researchers had jumped the gun.
Even as Russia insisted that claims that the vaccine was unsafe were groundless, criticism continued to build.
Among those mentioning ADE as a concern was Danny Altmann, professor of immunology at Imperial College.
Part of the problem, Altmann points out, is that the work behind Russia’s vaccine development has been so opaque that no one really knows how safe or even how effective it will be.
“I don’t think the Russian researchers have done anything wrong,” he told the Guardian, “but I think they’ve jumped the gun,” he added reflecting Gilligan’s language.
“If we are talking about safety then you have to be looking at issues like ADE, which was a concern that scuppered some efforts to develop a Sars vaccine, where it exacerbated an asthma-like response in lungs.”
It is not just the potential for issues such as ADE that concerns people like Altmann, who is optimistic that the hunt for a vaccine for Covid-19 is not “intractable”.
He says the ideal approach would have been to compare 150 or so different vaccine candidates transparently, using the same testing criteria, to ensure the world gets the best vaccine, not simply the first.
“No two of these candidates is going be alike in terms of safety, how effective they are or how cheap they are to produce,” he said.
“The reason we’re crying out for transparency and peer review is because those factors are very serious. There have been too many debacles in this pandemic. This is not another occasion to blunder in. You want to line up the candidates side by side.”
The lack of effective testing throws up other issues….
Image Credit: Amanda Scott/ Alias
News This Week
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
Deadly Hospital Fungus May Finally Have a Weakness
A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it. Researchers have identified a genetic process that could open the door to new treatments for a dangerous fungal infection [...]
Fever-Proof Bird Flu Variant Could Fuel the Next Pandemic
Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body’s main tools for slowing or stopping viral [...]
What could the future of nanoscience look like?
Society has a lot to thank for nanoscience. From improved health monitoring to reducing the size of electronics, scientists’ ability to delve deeper and better understand chemistry at the nanoscale has opened up numerous [...]
Scientists Melt Cancer’s Hidden “Power Hubs” and Stop Tumor Growth
Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they were able to halt cancer [...]
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
WASHINGTON -- A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported Wednesday. HPV, or human papillomavirus, is very common and spread [...]
